MA
IDXX icon

Mutual Advisors’s Idexx Laboratories IDXX Stock Holding History

Mutual Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$279K Sell
535
-9
-2% -$4.93K ﹤0.01% 1210
2026
Q2 		$286K Buy
544
+39
+8% +$21.9K 0.01% 1190
2026
Q1 		$284K Buy
505
+29
+6% +$18.6K 0.01% 1147
2025
Q4 		$322K Sell
476
-1
-0.2% -$681 0.01% 1051
2025
Q3 		$305K Buy
477
+46
+11% +$27.9K 0.01% 1046
2025
Q2 		$244K Buy
+431
New +$206K 0.01% 1057
2024
Q3 		– Sell
-806
Closed -$381K – 1136
2024
Q2 		$381K Buy
806
+338
+72% +$170K 0.01% 804
2024
Q1 		$253K Hold
468
– – 0.01% 941
2023
Q4 		$260K Buy
+468
New +$220K 0.01% 873
2023
Q2 		– Sell
-423
Closed -$212K – 1031
2023
Q1 		$212K Buy
+423
New +$202K 0.01% 911
2021
Q4 		– Sell
-381
Closed -$237K – 907
2021
Q3 		$237K Sell
381
-215
-36% -$144K 0.01% 778
2021
Q2 		$376K Buy
596
+50
+9% +$27.6K 0.02% 619
2021
Q1 		$267K Buy
+546
New +$274K 0.02% 654

Other funds holding IDXX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Mutual Advisors's IDXX Position: Q3 2026 in Review

Mutual Advisors reduced its Idexx Laboratories (IDXX) stake by 1.7% in Q3 2026, selling an estimated $4.93K and leaving 535 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #1210.

Mutual Advisors first reported a position in IDXX in Q1 2021 and has held it in 13 quarters since. The position peaked at $381K in Q2 2024. 1,073 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Mutual Advisors held 535 shares of Idexx Laboratories worth $279K as of Q3 2026.
  • Mutual Advisors sold 9 Idexx Laboratories shares in Q3 2026, an estimated $4.93K.
  • Idexx Laboratories made up ﹤0.01% of Mutual Advisors's portfolio in Q3 2026, its #1210 holding.
  • Mutual Advisors first reported a position in Idexx Laboratories in Q1 2021 and has held it in 13 quarters since.
  • Mutual Advisors's Idexx Laboratories position peaked at $381K in Q2 2024.
  • 1,073 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Mutual Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.